Ezetimibe prevents cholesterol gallstone formation in mice

Silvia Zúñiga1, Héctor Molina, Lorena Azocar

  • 1Departamento de Gastroenterología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

Summary

Ezetimibe (EZET) prevents gallstone formation in mice by inhibiting intestinal cholesterol absorption. This cholesterol-lowering agent also increased bile flow, suggesting potential for gallstone disease prevention in humans.